Efficacy of Roflumilast in Bronchiectasis Patients with Frequent Exacerbations: A Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial

BACKGROUND: Bronchiectasis patients with neutrophilic airway inflammation develop symptoms of chronic cough, sputum production, and recurrent exacerbations. Roflumilast has anti-inflammatory actions via decreased neutrophilic airway inflammation. The effectiveness of roflumilast to reduce bronchiect...

Descripción completa

Detalles Bibliográficos
Autores principales: Juthong, Siwasak, Panyarath, Pattaraporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743631/
https://www.ncbi.nlm.nih.gov/pubmed/34343424
http://dx.doi.org/10.4046/trd.2021.0051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743631/
https://www.ncbi.nlm.nih.gov/pubmed/34343424
http://dx.doi.org/10.4046/trd.2021.0051

Ejemplares similares